Publications by authors named "Sonya Heltshe"

Claim this Profile
C
Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes.
Oliver J McElvaney, Sonya L Heltshe, Don B Sanders, Natalie E West, Barbra Fogarty

J Cyst Fibros· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations.
Ranjani Somayaji, Jonathan D Cogen, Donald VanDevanter, John J LiPuma, Natalie E West, Sonya L Heltshe

J Cyst Fibros· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study.
Jessica E Pittman, Sarah Morgan, Morgan McCreary, Phuong T Vu, Peter Jorth, Sonya Heltshe

Ann Am Thorac Soc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.
Scott D Sagel, Phuong Vu, Sonya L Heltshe, George M Solomon, Andrea Kelly

J Cyst Fibros· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.
Nora C Burdis, Miranda C Bradford, Sonya L Heltshe, Tijana Milinic, Oliver J McElvaney

J Cyst Fibros· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor.
Scott D Sagel, T Spencer Poore, Brandie D Wagner, Jing Xie, Sonya L Heltshe

Ann Am Thorac Soc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation.
Samantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, Matthew M Willmering, J David Godwin, Sonya L Heltshe

Cell Host Microbe· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for Inconsistent Use of Covariate Adjustment in Group Sequential Trials.
Marlena S Bannick, Sonya L Heltshe, Noah Simon

Stat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for re-assessment of impact of repeated pregnancy on lung health in cystic fibrosis.
Amalia S Magaret, Sonya L Heltshe

Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol.
Christine M Liu, Jakob L Fischer, Edith T Zemanick, Jason C Woods, Karolin K Markarian, Sonya L Heltshe

ERJ Open Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application.
Mark N Warden, Sonya L Heltshe, Noah Simon, Stephen J Mooney, Nicole Mayer-Hamblett

Am J Epidemiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline-dependent improvement in CF studies, plausibility of bias.
Ellen Graham, Sonya L Heltshe, Amalia S Magaret

Contemp Clin Trials Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative.
Jonathan D Cogen, Sonya L Heltshe, Adam W Brothers, Donald R VanDevanter, Jeffrey S Gerber

J Cyst Fibros· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis.
MinJae Lee, Meghana Sathe, Baha Moshiree, Phuong T Vu, Sonya L Heltshe

J Cyst Fibros· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
Oliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, Natalie E West, Don B Sanders

Ann Am Thorac Soc· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Christina S Thornton, Lindsay J Caverly, Linda M Kalikin, Lisa A Carmody, Scott McClellan, Sonya L Heltshe

Ann Am Thorac Soc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location.
Laura S Gold, Ryan N Hansen, Sonya L Heltshe, Patrick A Flume, Christopher H Goss

J Cyst Fibros· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
Stacey L Martiniano, Silvia M Caceres, Katie Poch, Noel M Rysavy, Valerie K Lovell, Sonya L Heltshe

J Cyst Fibros· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations.
Sonya L Heltshe, Renee Russell, Donald R VanDevanter, Don B Sanders

J Cyst Fibros· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of hyperglycemia in cystic fibrosis pulmonary exacerbations.
Lina Merjaneh, Aniket R Sidhaye, Phuong T Vu, Sonya L Heltshe, Christopher H Goss

J Cyst Fibros· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.
Oliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, Natalie E West, Don B Sanders

J Cyst Fibros· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen.
J Kirk Harris, Brandie D Wagner, Charles E Robertson, Mark J Stevens, Conor Lingard, Sonya L Heltshe

J Cyst Fibros· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis.
Ranjani Somayaji, Madeline E Wessels, Tijana Milinic, Kathleen J Ramos, Nicole Mayer-Hamblett, Sonya Heltshe

J Cyst Fibros· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis.
Erica A Roesch, Tracey L Bonfield, Hillard M Lazarus, Jane Reese, Kathleen Hilliard, Sonya Heltshe

J Cyst Fibros· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist.
David P Nichols, Sarah J Morgan, Michelle Skalland, Anh T Vo, Jill M Van Dalfsen, Sonya L Heltshe

J Clin Invest· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis